Comments
Pharma major Dr Reddy’s consolidated net profit during the first quarter ended June 30, 2020 declined 13 per cent at ₹579 crore compared to ₹663 crore in the corresponding quarter of the previous financial year.
The total revenue of the Hyderabad-based company increased 15 per cent at ₹4,417.5 crore as against ₹3,843.5 crore in the same period last year.
“The current quarter’s financial performance has been strong across all parameters. I am glad that we have been able to serve our patients well and ensured continuity of business operations despite the challenging times,’’ GV Prasad, Co-Chairman and Managing Director, Dr Reddy’s, said on Wednesday.
“We have started integration of the acquired business from Wockhardt and executed two important licensing arrangements for treatment options for Covid-19. Currently, we are working towards bringing both these drugs to multiple markets,’’ he added.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.